Active Ingredient(s): Cytarabine, ARA-C
FDA Approved: * December 30, 1998
Pharm Company: * SICOR PHARMS
Category: Cancer

Cytarabine, also known as cytosine arabinoside (ara-C), is a chemotherapy medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and non-Hodgkin's lymphoma.[1] It is given by injection into a vein, under the skin, or into the cerebrospinal fluid.[1] There is a liposomal formulation for which there is tentative evidence of better outcomes in lymphoma involving the meninges.[1] ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.